Independent editorial publication
Editions · September 6, 2026
A clearer view of human progress.
The Good in the World
September 6, 2026
Lead story · Health & Medicine · 4 min
In a 500-patient trial, median overall survival reached 13.2 months with daraxonrasib, compared with 6.7 months for standard chemotherapy. The FDA has now approved the first-in-class RAS inhibitor for specified adults with metastatic pancreatic cancer.
Health & Medicine · 3 min
Intismeran combined with Keytruda met its main goals in 1,137 high-risk melanoma patients, reducing recurrence and distant spread compared with Keytruda alone. Detailed results and overall-survival data are still pending.
Education · 3 min
Between 2015 and 2023, upper-secondary completion by age 19 rose from 55% to 71%, while promotion improved, repetition fell and far more students entered full-time schools.
Technology · 3 min
In the first patient of an ongoing UCL-UCLH clinical trial, an AI system analyzed live surgical video and highlighted critical structures while the surgeon remained in control. The tumor was removed and the patient's vision improved.
Environment & Wildlife · 3 min
By the end of 2023, cameras had recorded more than 25,000 safe wildlife crossings at completed I-90 Snoqualmie Pass structures—including thousands of elk, deer and coyotes.
Pets · 3 min
Thirty big cats have begun journeys from the former Luján Zoo to accredited sanctuaries in South Africa and Colorado. More than 20 animals still need permanent homes.
Community & Humanity · 3 min
A UNICEF-UNHCR program exceeded its water-service target across displacement-affected communities in Ethiopia, Somalia and Sudan while reducing interruptions and production costs in participating areas.
History · 3 min
Launched on September 5, 1977, Voyager 1 transformed our understanding of Jupiter and Saturn, became the first human-made object in interstellar space and remains an active extended mission.